Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

SELL
$126.46 - $235.05 $15,807 - $29,381
-125 Reduced 73.96%
44 $8,000
Q2 2021

Jul 20, 2021

BUY
$129.91 - $234.98 $1,688 - $3,054
13 Added 8.33%
169 $40,000
Q4 2020

Jan 14, 2021

BUY
$65.74 - $169.86 $9,861 - $25,479
150 Added 2500.0%
156 $16,000
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $326 - $569
6 New
6 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Professional Financial Advisors, LLC Portfolio

Follow Professional Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Professional Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Professional Financial Advisors, LLC with notifications on news.